CBO's recent score tallied temporary PAMA delay as a cost rather than a savings, potentially making future delays less likely ...

With the approval, the company's automated clinical mass spec system, the Cobas I 601 analyzer, features an in vitro diagnostic menu of 39 tests.

The company intends to use the funding to advance its AI-powered microscopy system for infectious disease analysis.

The collaboration combines Guardant's diagnostics with Trial Library's AI-powered matching and patient navigation platform.

The digital immunoassay platform is designed to detect and quantify proteins at the single-molecule level in blood, serum, or plasma. The platform includes the Simoa HD-X Immunoassay Analyzer, which ...

The German startup is developing ultrasensitive lateral flow diagnostic tests that incorporate DNA origami signal amplification.

NEW YORK – Finnish diagnostics company Uniogen is on track to seek a CE-IVD mark for an early-stage ovarian cancer detection test by 2027. Currently available for research use only, the firm's Glyvar ...

Last week, readers were most interested in a story about FDA approving Cleveland Diagnostics' prostate cancer test.

The test could potentially deliver noninvasive results in less than one minute through analysis of exhaled volatile organic compounds.

NEW YORK – Roche announced Tuesday that its PCR-based test for vaginitis has received CE marking. The test is now available in countries accepting the designation. The Cobas Bacterial ...